Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue
+10.9%
EPS
−351.9%
Free cash flow
−11.5%
Total debt
+3.28%

Quarter to September 2026, against a year earlier

169.01 9.19 −5.16%
Market cap
$10.8B
P/E
0.0×
Fwd P/E
−615×
Dividend yield
—
F-score
6/9
Altman Z
7.49
Beneish M
−2.52
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
188.34 0.00 267.52 48.21 113.18 168.10 205.56 138.79 50.77 89.00
Piotroski F-Score
6 4 4 4 5 6 5 5 5 3
P/S ratio
12.48 12.69 15.80 11.21 21.73 27.50 16.55 11.90 10.03 10.00
Altman Z-Score
7.49 6.42 7.83 10.18 15.29 16.90 8.68 9.27 6.02 6.10
P/FCF ratio
215.98 83.67 133.33 107.29 305.20 277.58 101.49 115.48 118.11 322.68
Altman Z″-Score (non-manufacturers)
5.48 4.98 5.19 5.88 5.31 6.67 6.24 5.46 6.00 4.87
Beneish M-Score
(2.52) (2.76) (2.42) (2.41) (1.75) (1.96) (2.53) (2.36) (1.25) (2.52)
P/Operating CF
358.49 205.52 343.71 145.19 293.64 677.22 253.01 415.53 93.11 535.21
P/B ratio
4.38 4.08 5.08 4.70 8.33 6.59 4.22 3.75 2.40 6.20
EV/Sales
12.27 12.44 15.53 10.95 21.36 26.27 15.43 11.95 10.20 9.56
EV/EBITDA
60.17 157.32 82.71 31.63 65.94 89.22 64.68 50.38 58.77 46.90
EV/FCF
212.32 81.98 131.03 104.81 300.03 265.25 94.66 115.98 120.09 308.33
Current Ratio
8.37 8.41 6.74 2.47 2.48 2.83 13.28 2.12 9.63 8.74
Net Debt/EBITDA
(1.50) (4.62) (1.45) (0.75) (1.13) (4.15) (4.66) (1.96) (3.04) (2.18)
Debt/Equity
0.26 0.27 0.30 0.22 0.20 0.18 0.22 0.17 0.17 0.56
ROE
2.40% (1.30%) 1.84% 10.16% 7.82% 4.63% 2.56% 2.75% 7.46% 8.01%
ROA
1.69% (0.90%) 1.33% 7.61% 6.02% 3.63% 1.97% 2.19% 5.49% 5.37%
ROIC
1.83% (1.26%) 1.66% 8.25% 6.95% 4.03% 2.97% 3.09% 1.69% 8.17%
Return on Tangible Assets
4.12% (2.24%) 3.08% 23.70% 18.83% 9.22% 3.34% 9.33% 11.81% 6.56%
Average Days of Receivables
78.41 77.16 71.67 52.94 63.92 71.14 58.98 67.26 71.68 55.98
Earnings Yield
0.53% (0.31%) 0.37% 2.07% 0.88% 0.59% 0.49% 0.72% 1.97% 1.12%
Free Cash Flow Yield
0.46% 1.20% 0.75% 0.93% 0.33% 0.36% 0.99% 0.87% 0.85% 0.31%
Free Cash Flow per Share
1.63 2.55 1.34 0.70 0.87 0.69 0.91 0.43 0.31 0.10
Book value per Share
37.45 35.27 35.26 34.45 31.81 29.10 21.92 14.06 15.47 5.03
Free Cash Flow
91.93 142.49 74.93 38.74 47.74 36.28 44.06 18.73 12.00 3.24
EV/EBIT
164.20 0.00 205.82 39.06 85.64 137.83 115.60 89.20 102.87 62.56
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026